These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 31114222)

  • 41. The significance of De Ritis (aspartate transaminase/alanine transaminase) ratio in predicting pathological outcomes and prognosis in localized prostate cancer patients.
    Wang H; Fang K; Zhang J; Jiang Y; Wang G; Zhang H; Chen T; Shi X; Li Y; Duan F; Liu J
    Int Urol Nephrol; 2017 Aug; 49(8):1391-1398. PubMed ID: 28550473
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Preoperative prognostic nutritional index is a significant predictor of survival in patients with localized upper tract urothelial carcinoma after radical nephroureterectomy.
    Huang J; Yuan Y; Wang Y; Chen Y; Kong W; Xue W; Chen H; Zhang J; Huang Y
    Urol Oncol; 2017 Dec; 35(12):671.e1-671.e9. PubMed ID: 28826702
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Validation of the Pretreatment Neutrophil-to-Lymphocyte Ratio as a Prognostic Factor in a Large Cohort of Chinese Patients with Upper Tract Urothelial Carcinoma.
    Cao ZP; Guan B; Zhao GZ; Fang D; Xiong GY; Li XS; Zhou LQ
    Chin Med J (Engl); 2017 Sep; 130(17):2063-2068. PubMed ID: 28836549
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Preoperative Risk Classification Using Neutrophil-to-Lymphocyte Ratio and Albumin for Upper Tract Urothelial Carcinoma Treated with Radical Nephroureterectomy.
    Zhao Z; Xie S; Feng B; Zhang S; Sun Y; Guo H; Yang R
    Cancer Manag Res; 2020; 12():9023-9032. PubMed ID: 33061597
    [TBL] [Abstract][Full Text] [Related]  

  • 45. C-reactive protein: a biomarker of survival in patients with localized upper tract urothelial carcinoma treated with radical nephroureterectomy.
    Obata J; Kikuchi E; Tanaka N; Matsumoto K; Hayakawa N; Ide H; Miyajima A; Nakagawa K; Oya M
    Urol Oncol; 2013 Nov; 31(8):1725-30. PubMed ID: 23141922
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Predictive value of preoperative lymphocyte-to-monocyte ratio for patients with upper tract urothelial carcinoma.
    Li T; Xu H; Yang L; Tan P; Wei Q
    Clin Chim Acta; 2019 May; 492():50-56. PubMed ID: 30763574
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Preoperative serum pre-albumin as an independent prognostic indicator in patients with localized upper tract urothelial carcinoma after radical nephroureterectomy.
    Huang J; Wang Y; Yuan Y; Chen Y; Kong W; Chen H; Zhang J; Huang Y
    Oncotarget; 2017 May; 8(22):36772-36779. PubMed ID: 27906675
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Prognostic value of preoperative plasma fibrinogen level and platelet-to-lymphocyte ratio (F-PLR) in patients with localized upper tract urothelial carcinoma.
    Huang J; Yuan Y; Wang Y; Zhang J; Kong W; Chen H; Chen Y; Huang Y
    Oncotarget; 2017 May; 8(22):36761-36771. PubMed ID: 27901490
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Clinical significance of prognosis using the neutrophil-lymphocyte ratio and erythrocyte sedimentation rate in patients undergoing radical nephroureterectomy for upper urinary tract urothelial carcinoma.
    Sung HH; Jeon HG; Jeong BC; Seo SI; Jeon SS; Choi HY; Lee HM
    BJU Int; 2015 Apr; 115(4):587-94. PubMed ID: 24947340
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The Preoperative AST/ALT (De Ritis) Ratio Represents a Poor Prognostic Factor in a Cohort of Patients with Nonmetastatic Renal Cell Carcinoma.
    Bezan A; Mrsic E; Krieger D; Stojakovic T; Pummer K; Zigeuner R; Hutterer GC; Pichler M
    J Urol; 2015 Jul; 194(1):30-5. PubMed ID: 25623738
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Impact of the ASA Physical Status Score on Adjuvant Chemotherapy Eligibility and Survival of Upper Tract Urothelial Carcinoma Patients: a Multicenter Study.
    Kang HW; Seo SP; Kim WT; Kim YJ; Yun SJ; Lee SC; Choi YD; Ha YS; Kim TH; Kwon TG; Byun SS; Jeh SU; Kim WJ
    J Korean Med Sci; 2017 Feb; 32(2):335-342. PubMed ID: 28049247
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Long-Term Oncologic Outcomes of Laparoscopic Versus Open Radical Nephroureterectomy for Patients with T3N0M0 Upper Tract Urothelial Carcinoma: A Multicenter Cohort Study with Adjustment by Propensity Score Matching.
    Shigeta K; Kikuchi E; Abe T; Hagiwara M; Ogihara K; Anno T; Umeda K; Baba Y; Sanjo T; Shojo K; Mizuno R; Oya M
    Ann Surg Oncol; 2019 Oct; 26(11):3774-3781. PubMed ID: 31313043
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Robotic Radical Nephroureterectomy with Bladder Cuff Excision for Upper Tract Urothelial Carcinoma: A Trend Analysis of Utilization and a Comparative Study.
    Bae H; Chung JH; Song W; Kang M; Jeon HG; Jeong BC; Seo SI; Jeon SS; Lee HM; Sung HH
    Cancers (Basel); 2022 May; 14(10):. PubMed ID: 35626101
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Marital status impacts survival in patients with upper tract urothelial carcinoma: a population-based, propensity-matched study.
    Wang K; Mao W; Shi H; Wang G; Yin L; Xie J; Ian LH; Zhang H; Peng B
    Transl Androl Urol; 2020 Aug; 9(4):1611-1629. PubMed ID: 32944523
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Pretreatment serum pseudocholinesterase level as a novel prognostic biomarker for upper tract urothelial carcinoma.
    Zhang B; Shen C; Jin J; Song Y; Zhao Z; Zhang X; Wang G; Fan Y; Mi Y; Hu S; Cui Y; Zhou L; He Z; Yu W; Han W
    Int Urol Nephrol; 2016 Dec; 48(12):1993-1999. PubMed ID: 27554671
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Comparative analysis of comorbidity and performance indices for prediction of oncological outcomes in patients with upper tract urothelial carcinoma who were treated with radical nephroureterectomy.
    Aziz A; Fritsche HM; Gakis G; Kluth LA; Hassan Fa; Engel O; Dahlem R; Otto W; Gierth M; Denzinger S; Schwentner C; Stenzl A; Shariat SF; Fisch M; Burger M; Rink M
    Urol Oncol; 2014 Nov; 32(8):1141-50. PubMed ID: 24856977
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Prognostic Value of Lymphovascular Invasion in Upper Urinary Tract Urothelial Carcinoma after Radical Nephroureterectomy: A Systematic Review and Meta-Analysis.
    Liu W; Sun L; Guan F; Wang F; Zhang G
    Dis Markers; 2019; 2019():7386140. PubMed ID: 31565103
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Comparing Oncological and Perioperative Outcomes of Open versus Laparoscopic versus Robotic Radical Nephroureterectomy for the Treatment of Upper Tract Urothelial Carcinoma: A Multicenter, Multinational, Propensity Score-Matched Analysis.
    Grossmann NC; Soria F; Juvet T; Potretzke AM; Djaladat H; Ghoreifi A; Kikuchi E; Mari A; Khene ZE; Fujita K; Raman JD; Breda A; Fontana M; Sfakianos JP; Pfail JL; Laukhtina E; Rajwa P; Pallauf M; Poyet C; Cacciamani GE; van Doeveren T; Boormans JL; Antonelli A; Jamil M; Abdollah F; Ploussard G; Heidenreich A; Storz E; Daneshmand S; Boorjian SA; Rouprêt M; Rink M; Shariat SF; Pradere B
    Cancers (Basel); 2023 Feb; 15(5):. PubMed ID: 36900201
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Influence of American Society of Anesthesiologists Score on Oncologic Outcomes in Patients With Upper Tract Urothelial Carcinoma After Radical Nephroureterectomy: A Large-Sample Study in Two Institutions.
    Yuan Y; Wang Y; Zhang N; Mao X; Huang Y; Huang J; Ji N
    Front Oncol; 2021; 11():723669. PubMed ID: 34671552
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The Prevalence and Prognostic Role of PD-L1 in Upper Tract Urothelial Carcinoma Patients Underwent Radical Nephroureterectomy: A Systematic Review and Meta-Analysis.
    Lu Y; Kang J; Luo Z; Song Y; Tian J; Li Z; Wang X; Liu L; Yang Y; Liu X
    Front Oncol; 2020; 10():1400. PubMed ID: 32974145
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.